glp 1 inventor Who should win a Nobel for the science of the Ozempic revolution? How Lotte Bjerre Knudsen helped

As a result, it is also a chronic disease with significant morbidity and mortality rates over the world, with the number of individuals affected increasing at an alarming rate every day and anticipated to reach 700 million by 2045 [2]

5 GLP-1 trends to expect in 2026: Expanded uses, oral options, and more Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market

doi: 10.1172/jci.insight.140532 [DOI] [PMC free article] [PubMed] [Google Scholar] 110

Robust demand in key markets such as the US, Europe and China further contributed to its strong performance

Conclusion GLP-1 medications work by slowing digestion and reducing appetite, but these mechanisms can lead to gastrointestinal (GI) side effects for as many as 40% of patients

External resources For researchers serious about optimizing their weight management protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, comparison tools, and a community of thousands who have navigated these exact decisions